Perspectives

4/21/2025 4:33:21 PM

The Implications of AI-Assisted Drug Development on Patent Challenges

By Jon Turpin

The emergence of artificial intelligence (AI) in drug development has significant ramifications for the pharmaceutical industry, patent...

4/8/2025 3:29:18 PM

By Daniel McGee

A bill being considered in the North Carolina State Senate would commit time and money to the study of psychoactive chemicals and...

3/19/2025 3:09:23 PM

By Dae Lee

The Medicaid Drug Rebate Program (MDRP) is a cornerstone of pharmaceutical pricing regulation, requiring drug manufacturers to provide...

3/18/2025 7:18:19 PM

By Dae Lee

JPMorgan Chase & Co. is the latest major corporation to face a class action lawsuit from employees alleging mismanagement of their...

3/13/2025 8:08:49 PM

By Michael McLaughlin

Navigating the SuperBlack Ransomware Threat: Technical and Legal Considerations The emergence of the SuperBlack ransomware group has...

3/12/2025 1:59:49 PM

By Dae Lee

Florida’s Prescription Drug Reform Act is one of the most aggressive state-level PBM reform laws enacted in response to the Supreme...

3/10/2025 5:30:33 PM

By Michael McLaughlin

As ransomware evolves into an increasingly sophisticated threat- leveraging AI to increase its efficacy- organizations must adopt a...

12/31/2024 1:43:52 PM

By Michael McLaughlin

Cut off one head, and two more grow back. This ancient saying, inspired by the mythical hydra, perfectly captures the resilience of...

11/19/2024 6:45:02 PM

By Michael McLaughlin

International Fraud Awareness Week has kicked off amidst an evolving and increasingly pernicious threat landscape. In the U.S. alone,...

11/6/2024 2:48:44 PM

By Michael McLaughlin

Google has made significant strides in enhancing security across its platform, with a particular focus on Gmail, which serves over 2.5...

10/28/2024 7:41:20 PM

By Michael McLaughlin

The U.S. Consumer Financial Protection Bureau (CFPB) is intensifying scrutiny of workplace surveillance practices due to concerns over...

10/22/2024 3:11:04 PM

By Barbara Binzak Blumenfeld

I am pleased to be moderating the Industry Leaders Fireside Chat on day one of the Cell & Gene Therapy Regulatory Affairs Summit in...